Isracann Biosciences Inc (ISCNF)
0.0001
0.00 (0.00%)
USD |
OTCM |
Apr 23, 16:00
Isracann Biosciences Total Assets (Quarterly): 3.085M for Aug. 31, 2022
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2022 | 3.085M |
| May 31, 2022 | 3.232M |
| February 28, 2022 | 2.179M |
| November 30, 2021 | 2.676M |
| August 31, 2021 | 3.114M |
| May 31, 2021 | 3.643M |
| February 28, 2021 | 20.26M |
| November 30, 2020 | 19.56M |
| August 31, 2020 | 20.65M |
| May 31, 2020 | 20.38M |
| February 29, 2020 | 36.84M |
| November 30, 2019 | 40.01M |
| August 31, 2019 | 11.49M |
| May 31, 2019 | 12.11M |
| February 28, 2019 | 9.038M |
| November 30, 2018 | 5.226M |
| August 31, 2018 | 7.523M |
| May 31, 2018 | 11.29M |
| February 28, 2018 | 12.34M |
| November 30, 2017 | 4.390M |
| August 31, 2017 | 0.6584M |
| May 31, 2017 | 0.7481M |
| February 28, 2017 | 0.8712M |
| November 30, 2016 | 1.022M |
| Date | Value |
|---|---|
| August 31, 2016 | 1.164M |
| May 31, 2016 | 0.8034M |
| February 29, 2016 | 0.7876M |
| August 31, 2015 | 0.8182M |
| May 31, 2015 | 0.9083M |
| February 28, 2015 | 0.8898M |
| November 30, 2014 | 1.066M |
| August 31, 2014 | 1.247M |
| May 31, 2014 | 0.1572M |
| February 28, 2014 | 0.173M |
| November 30, 2013 | 0.1962M |
| August 31, 2013 | 0.2213M |
| May 31, 2013 | 0.246M |
| February 28, 2013 | 0.2632M |
| November 30, 2012 | 0.2882M |
| August 31, 2012 | 0.2862M |
| May 31, 2012 | 0.3078M |
| February 29, 2012 | 0.3347M |
| November 30, 2011 | 0.3415M |
| August 31, 2011 | 0.3983M |
| May 31, 2011 | 0.4007M |
| February 28, 2011 | 0.4143M |
| November 30, 2010 | 0.4264M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
2.179M
Minimum
Feb 2022
40.01M
Maximum
Nov 2019
14.23M
Average
11.80M
Median
Total Assets (Quarterly) Benchmarks
| Acasti Pharma Inc | 76.18M |
| Aurinia Pharmaceuticals Inc | 548.06M |
| Edesa Biotech Inc | 7.832M |
| Lexaria Bioscience Corp | 6.352M |
| Liminal Biosciences Inc (DELISTED) | 23.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.990M |
| Shareholders Equity (Quarterly) | 0.0979M |